144 related articles for article (PubMed ID: 2465786)
1. Construction and characterization of hybrid hepatitis B antigen particles carrying a poliovirus immunogen.
Delpeyroux F; Crainic R; Blondel B; Horaud F; Van der Werf S; Girard M; Lagarde D; Mazert MC; Streeck RE
Biochimie; 1988 Aug; 70(8):1065-73. PubMed ID: 2465786
[TBL] [Abstract][Full Text] [Related]
2. A poliovirus neutralization epitope expressed on hybrid hepatitis B surface antigen particles.
Delpeyroux F; Chenciner N; Lim A; Malpièce Y; Blondel B; Crainic R; van der Werf S; Streeck RE
Science; 1986 Jul; 233(4762):472-5. PubMed ID: 2425433
[TBL] [Abstract][Full Text] [Related]
3. Presentation and immunogenicity of the hepatitis B surface antigen and a poliovirus neutralization antigen on mixed empty envelope particles.
Delpeyroux F; Peillon N; Blondel B; Crainic R; Streeck RE
J Virol; 1988 May; 62(5):1836-9. PubMed ID: 2451759
[TBL] [Abstract][Full Text] [Related]
4. Structural factors modulate the activity of antigenic poliovirus sequences expressed on hybrid hepatitis B surface antigen particles.
Delpeyroux F; Van Wezel E; Blondel B; Crainic R
J Virol; 1990 Dec; 64(12):6090-100. PubMed ID: 2173781
[TBL] [Abstract][Full Text] [Related]
5. Insertions in the hepatitis B surface antigen. Effect on assembly and secretion of 22-nm particles from mammalian cells.
Delpeyroux F; Chenciner N; Lim A; Lambert M; Malpièce Y; Streeck RE
J Mol Biol; 1987 May; 195(2):343-50. PubMed ID: 2821275
[TBL] [Abstract][Full Text] [Related]
6. Induction of virus-neutralizing antibodies by bacteria expressing the C3 poliovirus epitope in the periplasm. The route of immunization influences the isotypic distribution and the biologic activity of the antipoliovirus antibodies.
LeClerc C; Martineau P; Van der Werf S; Deriaud E; Duplay P; Hofnung M
J Immunol; 1990 Apr; 144(8):3174-82. PubMed ID: 2157762
[TBL] [Abstract][Full Text] [Related]
7. Deletion and insertion mutants of HBsAg particles.
Machein U; Nagel R; Prange R; Clemen A; Streeck RE
Arch Virol Suppl; 1992; 4():133-6. PubMed ID: 1333319
[TBL] [Abstract][Full Text] [Related]
8. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
9. Minor displacements in the insertion site provoke major differences in the induction of antibody responses by chimeric parvovirus-like particles.
Rueda P; Hurtado A; del Barrio M; Martínez-Torrecuadrada JL; Kamstrup S; Leclerc C; Casal JI
Virology; 1999 Oct; 263(1):89-99. PubMed ID: 10544085
[TBL] [Abstract][Full Text] [Related]
10. Critical role of neighbouring sequences on the immunogenicity of the C3 poliovirus neutralization epitope expressed at the surface of recombinant bacteria.
van der Werf S; Charbit A; Leclerc C; Mimic V; Ronco J; Girard M; Hofnung M
Vaccine; 1990 Jun; 8(3):269-77. PubMed ID: 1694613
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of poliovirus B and T cell epitopes presented by hybrid porcine parvovirus particles.
Sedlik C; Sarraseca J; Rueda P; Leclerc C; Casal I
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2361-8. PubMed ID: 7561778
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
Schödel F; Peterson D; Milich D
Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
[TBL] [Abstract][Full Text] [Related]
13. Properties of modified hepatitis B virus surface antigen particles carrying preS epitopes.
Prange R; Werr M; Birkner M; Hilfrich R; Streeck RE
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2131-40. PubMed ID: 7561750
[TBL] [Abstract][Full Text] [Related]
14. Molecular context of a viral T cell determinant within a chimeric bacterial protein alters the diversity of its T cell recognition.
Lo-Man R; Martineau P; Betton JM; Hofnung M; Leclerc C
J Immunol; 1994 Jun; 152(12):5660-9. PubMed ID: 7515911
[TBL] [Abstract][Full Text] [Related]
15. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.
Kucinskaite-Kodze I; Pleckaityte M; Bremer CM; Seiz PL; Zilnyte M; Bulavaite A; Mickiene G; Zvirblis G; Sasnauskas K; Glebe D; Zvirbliene A
Virus Res; 2016 Jan; 211():209-21. PubMed ID: 26541316
[TBL] [Abstract][Full Text] [Related]
16. Identification of hepatitis B virus polypeptides encoded by the entire pre-s open reading frame.
Wong DT; Nath N; Sninsky JJ
J Virol; 1985 Jul; 55(1):223-31. PubMed ID: 2409297
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
18. Construction of a poliovirus type 1/type 2 antigenic hybrid by manipulation of neutralization antigenic site II.
Murdin AD; Wimmer E
J Virol; 1989 Dec; 63(12):5251-7. PubMed ID: 2479772
[TBL] [Abstract][Full Text] [Related]
19. A frameshift mutation in the pre-S region of the human hepatitis B virus genome allows production of surface antigen particles but eliminates binding to polymerized albumin.
Persing DH; Varmus HE; Ganem D
Proc Natl Acad Sci U S A; 1985 May; 82(10):3440-4. PubMed ID: 3858831
[TBL] [Abstract][Full Text] [Related]
20. In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice.
Marsac D; Puaux AL; Rivière Y; Michel ML
Immunobiology; 2005; 210(5):305-19. PubMed ID: 16164038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
